Royal Bank of Canada’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Royal Bank of Canada’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-197,167	Closed	-$1.2M	–	8266
2021 Q3	$1.2M	Buy	197,167 +4,703	+2%	+$29.3K	﹤0.01%	3506
2021 Q2	$1.58M	Buy	192,464 +8,963	+5%	+$76.2K	﹤0.01%	3259
2021 Q1	$1.64M	Sell	183,501 -12,376	-6%	-$142K	﹤0.01%	3163
2020 Q4	$2.26M	Sell	195,877 -57,756	-23%	-$671K	﹤0.01%	2805
2020 Q3	$2.64M	Sell	253,633 -7,550	-3%	-$92.5K	﹤0.01%	2457
2020 Q2	$3.43M	Sell	261,183 -63,476	-20%	-$658K	﹤0.01%	2210
2020 Q1	$2.56M	Sell	324,659 -37,537	-10%	-$565K	﹤0.01%	2287
2019 Q4	$7.5M	Sell	362,196 -16,282	-4%	-$275K	﹤0.01%	1843
2019 Q3	$5.19M	Buy	378,478 +21,511	+6%	+$255K	﹤0.01%	2052
2019 Q2	$4.39M	Sell	356,967 -2,344	-0.7%	-$27K	﹤0.01%	2172
2019 Q1	$4.48M	Buy	359,311 +8,441	+2%	+$113K	﹤0.01%	2095
2018 Q4	$3.97M	Sell	350,870 -210,546	-38%	-$3.3M	﹤0.01%	2159
2018 Q3	$10.5M	Buy	561,416 +12,114	+2%	+$278K	0.01%	1590
2018 Q2	$14.2M	Sell	549,302 -20,099	-4%	-$522K	0.01%	1295
2018 Q1	$12.8M	Buy	569,401 +416	+0.1%	+$10.2K	0.01%	1377
2017 Q4	$14.2M	Buy	568,985 +112,601	+25%	+$2.76M	0.01%	1369
2017 Q3	$11M	Buy	456,384 +71,819	+19%	+$1.69M	0.01%	1463
2017 Q2	$7.78M	Buy	384,565 +75,148	+24%	+$1.57M	﹤0.01%	1671
2017 Q1	$8.33M	Buy	309,417 +44,362	+17%	+$906K	0.01%	1582
2016 Q4	$5.04M	Buy	265,055 +150,507	+131%	+$2.88M	﹤0.01%	1945
2016 Q3	$2.24M	Buy	114,548 +46,490	+68%	+$786K	﹤0.01%	2467
2016 Q2	$1.02M	Buy	68,058 +39,165	+136%	+$492K	﹤0.01%	3094
2016 Q1	$266K	Buy	28,893 +1,566	+6%	+$19K	﹤0.01%	4165
2015 Q4	$527K	Sell	27,327 -7,117	-21%	-$124K	﹤0.01%	3727
2015 Q3	$512K	Buy	34,444 +31,978	+1,297%	+$750K	﹤0.01%	3473
2015 Q2	$54K	Buy	2,466 +1,466	+147%	+$29.6K	﹤0.01%	5180
2015 Q1	$23K	Buy	+1,000	New	+$23.2K	﹤0.01%	5307